X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-09-26 | SGMO | Biogen Inc. | 10% | S - Sale | $0.50 | -6,000,000 | 17,652,466 | -25% | -$3,000,000 | ||||||
| M | 2022-08-29 | SGMO | Biogen Inc. | 10% | S - Sale | $5.31 | -500,000 | 23,652,466 | -2% | -$2,657,240 | |||||
2022-06-03 | SGMO | Markels John | Dir | P - Purchase | $3.69 | +6,784 | 32,484 | +26% | +$25,029 | ||||||
2022-06-01 | SGMO | Parker H Stewart | Dir | P - Purchase | $3.60 | +5,000 | 48,700 | +11% | +$17,996 | ||||||
2021-12-28 | SGMO | Biogen Inc. | 10% | S - Sale | $8.51 | -2,764 | 24,152,466 | 0% | -$23,522 | ||||||
| M | 2021-12-23 | SGMO | Biogen Inc. | 10% | S - Sale | $8.55 | -81,787 | 24,155,230 | 0% | -$699,666 | |||||
2021-12-09 | SGMO | Biogen Inc. | 10% | S - Sale | $8.56 | -23,660 | 24,237,017 | 0% | -$202,541 | ||||||
| M | 2021-12-07 | SGMO | Biogen Inc. | 10% | S - Sale | $8.59 | -127,992 | 24,260,677 | -1% | -$1,099,265 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |